Navigation Links
Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
Date:5/5/2008

el is applied, it absorbs directly into the bloodstream without having to pass through the liver. Divigel(R) also offers dosing flexibility with three different strengths (0.25 mg estradiol/day, 0.5 mg estradiol/day and 1.0 mg estradiol/day) to individualize treatment for each woman.

Important Safety Information for Patients

The following are not all the possible risks for Divigel(R). Please read the full Patient Information leaflet and talk to your healthcare provider.

Estrogens increase the chance of getting cancer of the uterus. Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause. In general, the addition of a progestin is recommended for women with a uterus to reduce the chance of getting cancer of the uterus.

Do not use estrogens, with or without progestins, to prevent heart disease, heart attacks, or strokes. Using estrogens, with or without progestins, may increase your chance of getting heart attacks, strokes, breast cancer, and blood clots.

Do not use estrogens, with or without progestins, to prevent dementia. Using estrogens, with or without progestins, may increase your risk of dementia.

Do not use estrogen products, including Divigel(R), if you have unusual vaginal bleeding, currently have or have had certain cancers, had a stroke or heart attack in the past year, currently have or have had blood clots, currently have or have had liver problems, are allergic to any Divigel(R) ingredients, or think you may be pregnant.

The most common side effects for all estrogen products are headache, breast pain, irregular vaginal bleeding or spotting, stomach/abdominal cramps and bloating, nausea and vomiting, and hair loss. Less common but serious side effects include breast cancer, cancer of the uterus, stroke, heart a
'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
2. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
3. LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity
4. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Clinically Proven Treatment Offers Help to Rosacea Sufferers
8. Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate
9. St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable
10. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
11. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015  Cardica, Inc. (Nasdaq: CRDC ) today announced ... quarter ended June 30, 2015, on Thursday, August 6, 2015, ... call at 4:30 p.m. Eastern Time to discuss the financial ... Conference Call Details To access the live conference ... via phone, please dial 877-703-6106 from the United ...
(Date:7/27/2015)... 27, 2015 Syneron Medical Ltd. ... global market leader in the aesthetic medical device marketplace, ... Food and Drug Safety (MFDS) regulatory clearance for the ... can fulfill PicoWay orders from its Korean distribution partner, ... in the third quarter 2015. Amit Meridor, ...
(Date:7/27/2015)... 27, 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), ... treatment of chronic pain, today announced that it ... Heath Canada to conduct a multiple ... REL-1017), its novel, N-methyl-D-aspartate (NMDA) receptor antagonist being ... "We are very encouraged by the initial ...
Breaking Medicine Technology:Cardica To Announce Fiscal 2015 Fourth Quarter Financial Results On Thursday, August 6, 2015 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 3
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... September 30, 2011 and provided a business update.  The ... and 2010, as reported in accordance with accounting principles ... million and $0.6 million, respectively.  The net losses for ...
... 7, 2011 Planet Biopharmaceuticals, Inc. and its wholly ... company focused on providing products for allergy and asthma ... sale of ALLERGY CONTROL PRODUCTS, INC., a Delaware corporation("ACP") ... liability company. Theron E. Odlaug, Ph. D., ...
Cached Medicine Technology:Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 7
(Date:7/28/2015)... ... July 28, 2015 , ... North American Seminars will ... fall of 2015 . These seventeen courses are pre-approved for CME credit ... Functional Mobility in the Older Adult , August 22, 2015 - August ...
(Date:7/28/2015)... ... ... the Veterans Fund of the United States, managing the United Veteran Beacon House (UVBH) for ... to help homeless Veterans by giving them “A hand up – not a hand out.” ... assists and supports Vets through the Veterans Fund of the United States (VFUS), ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s New ... http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is hard ... can get messy in a hurry. In a 46-page draft guidance released in January, ...
(Date:7/27/2015)... , ... July 28, 2015 , ... The National ... inductee into the NAPW VIP Woman of the Year Circle. She is recognized with ... 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... wound center management. Earlier this year Wound Care Advantage beta launched ... for WCA wound centers. Customized learning paths allow for clinicians, physicians, hyperbaric ...
Breaking Medicine News(10 mins):Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3
... distributed to Kids attending the event with their parents. Food, Entertainment ... ,Florida KidCare - Back to School - Enrollment Fair Sunday, August 3, ... - Shoppes of Cresthaven - (Military Trail & Cresthaven Blvd) West Palm ... ...
... 1 Mark Merritt, President,of the Pharmaceutical ... response to new comparative effectiveness legislation,introduced late ... Max Baucus,(D-Mont.) and Senate Budget Committee Chair ... Baucus and Conrad for helping advance the,discussion ...
... 1 Community-based oral health,programs in Michigan, Ohio, ... to $5,000 from the Delta Dental Foundation,s third ... by Nancy E. Hostetler,senior vice president of the ... of $70,000 will be awarded in competitive grants,this ...
... it,s unclear whether treating the breathing disorder cuts the ... News) -- The interrupted nighttime breathing of sleep apnea ... report. , Earlier studies have linked sleep apnea to ... in sleep centers rather than in the general community. ...
... 2008) -- Quality of care varies greatly for the treatment ... country and category of health care facility, suggesting the potential ... to a new study that was published in the Aug. ... (2008: Vol. 26, Issue 22). , The inconsistencies in care ...
... of Medicine have discovered that a protein called FOXA2 controls ... liver. FOXA2 may become the focus for new therapies to ... study was published online this week in Nature Medicine ... in the gall bladder and transported through ducts to the ...
Cached Medicine News:Health News:Florida KidCare News Conference and Back to School Enrollment Fair 2Health News:Delta Dental Foundation Calls for Applicants for Annual Community Mini-Grant Program 2Health News:Sleep Apnea Boosts Death Risk 2Health News:Sleep Apnea Boosts Death Risk 3Health News:Disparities in prostate cancer treatment suggest ways to improve care 2Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2
... provide you with everything you need ... evoked potential, or electro-oculogram. The ultra-bright ... to perform ERGs you never imagined ... negative response, and s-cone ERGs. Wireless ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... designed for high throughput microplate processing. The ... Stacker that handles up to 60 microplates ... model is equipped with a dual direct ... may be interfaced to increase flexibility as ...
... Processor is a precise, reliable and ... has been designed for OEM production. ... customised according to the method bottles ... able to process automatically the whole ...
Medicine Products: